StonvexLoading…
StonvexStonvexStonvexCore line items from CISS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $34.76M | $42.30M | $28.74M | $3.29M |
Operating Income | $1.36M | $10.06M | $10.43M | $552.06K |
Net Income | $10.47M | $-2.75M | $9.29M | $551.59K |
EPS (Diluted) | $3.98 | $-351.58 | $18911.99 | $110.78 |
Total Assets | $98.49M | $100.49M | $95.47M | $39.86M |
Total Liabilities | $3.39M | $29.13M | $39.93M | $965.47K |
Cash & Equivalents | $616.64K | $4.64M | $695.29K | $0.00 |
Free Cash Flow OCF − CapEx | $3.84M | $23.35M | $1.34M | $-38.34M |
Shares Outstanding | 659.67K | 35.32K | 5.83K | 500 |